ETON News and Press, Eton Pharmaceutcials Inc. From 08/10/23

Total Q2 revenue of $12.0 million and net income of $4.6 million Product sales and royalty revenue of $6.5 million up 175% from Q2 2022 and 22% from Q1 2023 $21.6 million of cash on hand Launched Betaine Anhydrous Management to hold conference call today at 4:30pm ET DEER ...

2023-08-09 17:35:06 ET Eton Pharmaceuticals ( NASDAQ: ETON ) is scheduled to announce Q2 earnings results on Thursday, August 10th, after market close. The consensus EPS Estimate is -$0.09 (-50.0% Y/Y) and the consensus Revenue Estimate is $6.51M (-12.0% Y/Y).Over the last 1...

DEER PARK, Ill., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report second quarter 2023 financial results on Thursday, August ...

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update PR Newswire DALLAS , July 17, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and m...

NEW YORK, NY / ACCESSWIRE / June 29, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Eton Pharmaceuticals, Inc. ("Eton" or the "Company") (NASDAQ:ETON). Investors who purchased Eton securities are encouraged to obtain additional informat...

2023-06-28 10:09:16 ET Gainers: Minerva Neurosciences ( NERV ) +51% . Regional Health Properties ( RHE ) +12% . Genfit ( GNFT ) +11% . RenovoRx ( RNXT ) +11% . OPKO Health ( OPK ) +5% . Losers: Cognition Therapeutics ( C...

2023-06-28 08:18:51 ET AST SpaceMobile ( ASTS ) -30% on pricing upsized $59.4M equity offering. American Rebel Holdings ( AREB ) -27% . Eton Pharmaceuticals ( ETON ) -15% as FDA rejects methanol poisoning therapy . Centogene ( CNTG ) -12% ...

DEER PARK, Ill., June 28, 2023 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Let...

2023-05-11 19:04:09 ET Eton Pharmaceuticals, Inc. (ETON) Q1 2023 Earnings Conference Call May 12, 2023 4:30 PM ET Company Participants David Krempa - Chief Business Officer Sean Brynjelsen - CEO James Gruber - CFO Conference Call Participants Raghuram...

2023-05-11 16:04:53 ET Eton Pharmaceuticals press release ( NASDAQ: ETON ): Q1 GAAP EPS of -$0.10 beats by $0.04 . Revenue of $5.3M (+143.1% Y/Y) beats by $0.74M . For further details see: Eton Pharmaceuticals GAAP EPS of -$0.10 beats by $0.04, revenue of...